SOPHiA Genetics launches SOPHiA DDM to assist Agilent customers
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
Agilent Technologies Inc. announced the contribution of Agilent AriaMx Real-Time qPCR instruments to five research hospitals in India to support their COVID-19 initiatives and help them serve the community at large
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
The award recognizes and supports promising women scientists
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
Researchers from IIT Bombay and QIMR Berghofer Medical Research Institute, Australia have developed this method, based on the Agilent Cary 630 FTIR Spectrometer
Subscribe To Our Newsletter & Stay Updated